Antistaphylococcal immunoglobulins to prevent staphylococcal infection in very low birth weight infants

Cochrane Database of Systematic Reviews

Volumn , Issue 2, 2007, Pages

  Shah, Prakeshkumar ^a   Kaufman, D ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; VANCOMYCIN;

ALLERGIC REACTION; BRAIN HEMORRHAGE; CHRONIC LUNG DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; GESTATIONAL AGE; HUMAN; LEUKOMALACIA; LOW BIRTH WEIGHT; NECROTIZING ENTEROCOLITIS; NEWBORN INTENSIVE CARE; PATENT DUCTUS ARTERIOSUS; RANDOMIZED CONTROLLED TRIAL; REVIEW; STAPHYLOCOCCUS INFECTION; TREATMENT OUTCOME;

EID: 44949220246     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD006449     Document Type: Review

References (24)

1. Adams-Chapman 2006 Adams-Chapman I, Stoll BJ. Neonatal infection and long-term neurodevelopmental outcome in the preterm infant. Current Opinion in Infectios Diseases 2006;19:290-7. [MEDLINE: 11].
2. Banerjea 2002 Banerjea MC, Speer CP. The current role of colony-stimulating factors in prevention and treatment of neonatal sepsis. Seminars in Neonatology 2002;7:335-49. [MEDLINE: 21].
3. Bell 1978 Bell MJ, Ternberg JL, Feigin RD, Keating JP, Marshall R, Barton L, et al.Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging. Annals of Surgery 1978;187:1-7.
4. Capparelli 2005 Capparelli EV, Bloom BT, Kueser TJ, Oelberg DG, Bifano EM, White RD, et al.Multicenter study to determine antibody concentrations and assess the safety of administration of INH-A21, a donor-selected human Staphylococcal immune globulin, in low-birth-weight infants. Antimicrobial Agents and Chemotherapy 2005;49:4121-7. [MEDLINE: 2].
5. Conner 2004 Conner JM, Soll RF, Edwards WH. Topical ointment for preventing infection in preterm infants. Cochrane Database of Systematic Reviews 2004, Issue 1. Art. No.: CD001150. DOI: 10.1002/14651858.CD001150. pub2.
6. Fanaroff 1998 Fanaroff AA, Korones SB, Wright LL, Verter J, Poland RL, Bauer CR, et al.Incidence, presenting features, risk factors and significance of late onset septicemia in very low birth weight infants. The National Institute of Child Health and Human Development Neonatal Research Network. Pediatric Infectious Disease Journal 1998;17:593-8. [MEDLINE: 10].
7. Graham 2004 Graham EM, Holcroft CJ, Rai KK, Donohue PK, Allen MC. Neonatal cerebral white matter injury in preterm infants is associated with culture positive infections and only rarely with metabolic acidosis. American Journal of Obstetric and Gynecology 2004;191:1305-10. [MEDLINE: 18].
8. Gray 1995 Gray JE, Richardson DK, McCormick MC, Goldmann DA. Coagulase-negative staphylococcal bacteremia among very low birth weight infants: relation to admission illness severity, resource use, and outcome. Pediatrics 1995;95:225-30. [MEDLINE: 17].
9. Horbar 2001 Horbar JD, Rogowski J, Plsek PE, Delmore P, Edwards WH, Hocker J, et al.Collaborative quality improvement for neonatal intensive care. NIC/Q Project Investigators of the Vermont Oxford Network. Pediatrics 2001;107:14-22. [MEDLINE: 19].
10. Kaufman 2004 Kaufman D, Fairchild KD. Clinical microbiology of bacterial and fungal sepsis in very-low-birth-weight infants. Clinical Microbiological Review 2004;17:638-80. [MEDLINE: 20].
11. Kaufman 2006 Kaufman D. Veronate (Inhibitex). Current Opinion on Investigational Drugs 2006;7:172-9. [MEDLINE: 2].
12. Ohlsson 2004 Ohlsson A, Lacy JB. Intravenous immunoglobulin for suspected or subsequently proven infection in neonates. Cochrane Database of Systematic Reviews 2004, Issue 1.Art. No.: CD001239. DOI: 10.1002/14651858.CD001239.pub2.
13. Ohlsson 2004a Ohlsson A, Lacy JB. Intravenous immunoglobulin for preventing infection in preterm and/or low-birth-weight infants. Cochrane Database of Systematic Review 2004, Issue 1.
14. Papile 1978 Papile LA, Burstein J, Burstein R, Koffler H. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm. Journal of Pediatrics 1978;92:529-34.
15. Patti 2005 Patti JM. Vaccines and immunotherapy for staphylococcal infections. International Journal of Artificial Organs 2005;28:1157-62.
16. Schroeder 1995 Schroeder HW, Jr, Mortari F, Shiokawa S, Kirkham PM, Elgavish RA, Bertrand FE 3rd. Developmental regulation of the human antibody repertoire. Annals of New York Academy of Science 1995;764:242- 60.
17. Shennan 1988 Shennan AT, Dunn MS, Ohlsson A, Lennox K, Hoskins EM. Abnormal pulmonary outcomes in premature infants: prediction from oxygen requirement in the neonatal period. Pediatrics 1988;82:527-32.
18. Singh-Grewal 2006 Singh-Grewal D, Kemp A, Wong M. A prospective study of the immediate and delayed adverse events following intravenous immunoglobulin infusions. Archives of Disease of Childhood 2006;91:651-4.
19. Splawski 1991 Splawski JB, Jelinek DF, Lipsky PE. Delineation of the functional capacity of human neonatal lymphocytes. Journal of Clinical Investigations 1991;87:545-53. [MEDLINE: 9].
20. Stoll 2002 Stoll BJ, Hansen N, Fanaroff AA, Wright LL, Carlo WA, Ehrenkranz RA, et al.Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics 2002;110:285-91. [MEDLINE: 1].
21. Stoll 2004 Stoll BJ, Hansen NI, Adams-Chapman I, Fanaroff AA, Hintz SR, Vohr B, et al.Neurodevelopmental and growth impairment among extremely low-birth-weight infants with neonatal infection. Journal of the American Medical Association 2004;292:2357-65. [MEDLINE: 1].
22. Vernachio 2006 Vernachio JH, Bayer AS, Ames B, Bryant D, Prater BD, Syribeys PJ, Gorovits EL, Patti JM. Human immunoglobulin G recognizing fibrinogen-binding surface proteins is protective against both Staphylococcus aureus and Staphylococcus epidermidis infections in vivo. Antimicrobial Agents and Chemotherapy 2006;50:511-8. [MEDLINE: 1].
23. Weisman 1994 Weisman LE, Cruess DF, Fischer GW. Opsonic activity of commercially available standard intravenous immunoglobulin preparations. Pediatric Infectious Disease Journal 1994;13:1122-5. [MEDLINE: 3].
24. Weisman 2004 Weisman LE. Coagulase-negative staphylococcal disease: emerging therapies for the neonatal and pediatric patient. Current Opinion in Infectious Diseases 2004;17:237-41. [MEDLINE: 12].